Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesCardiovascular involvement in primary systemic vasculitis
Best Practice & Research: Clinical Rheumatology, 07/02/09
Mukhtyar C et al. – A review summarizes data available for the effect of primary systemic vasculitis on cardiovascular endpoints (coronary artery disease, congestive cardiac failure, hypertension, aortic aneurysm) in all age groups. A discussion is presented of the interplay between activated endothelium, autoimmune mechanisms and treatment factors to produce a direct insult or increased atherogenic potential of primary systemic vasculitis. Recommendations for cardiovascular endpoints are offered.
Today in Vasculitic Syndromes...keeping you current
Receive free subspecialty "5-minute updates" via email
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçets disease refractory to standard immunosuppressive drugs
Rheumatology International, 10/30/09
Cutaneous vasculitis induced by TNF inhibitors: a report of three cases
Modern Rheumatology, 10/16/09
Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan
Modern Rheumatology, 10/14/09
Sponsor
Article Search
Sponsor